The Terry Fox Research Institute (TFRI) has joined forces with the Canadian Institutes of Health Research and partners to advance cancer prevention through a groundbreaking new funding initiative. Marking TFRI’s first dedicated investment in cancer prevention research, the program supports innovative projects across… Read More
Health Research BC is investing $6.3 million over three years to advance research that will help seniors age comfortably at home, stay connected, and live healthier, more independent lives. The Advancing the… Read More
– Study met primary endpoint (p-value = 0.012) -First registrational study to specifically evaluate a targeted treatment for patients living with ocular MG -Results support planned Supplemental Biologics License Application… Read More
Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseases HS235 offers potential to treat pulmonary hypertension (PH) patients while reducing the risk… Read More
30,000 ft2 center will help biopharma shorten development timelines, reduce risk, and scale with confidence Supports multiple modalities including mAbs, pDNA/mRNA, recombinant proteins, and viral vectors Cytiva, a Danaher company and… Read More
